Search
Menu
Home
HTB
2007
July
July 2007
Contents
Editorial
Volume 8 Number 6/7 June/July 2007
Treatment alerts
Roche recalls nelfinavir (Viracept) due to chemical impurity
European Medicines Agency press release on the nelfinavir recall
Notification of product recall due to Class 1 drug alert
EMEA questions and answers on the nelfinavir recall
Conference reports
XVI International HIV Drug Resistance Workshop, 12-16 June 2007, Barbados
Integrase inhibitors and resistance
Treatment failure and tropism changes in maraviroc trial related to previously undetected CXCR4, rather than a mutational shift from CCR5
Mechanisms of failure to CCR5 inhibitors is not explained by mutation in the V3 loop, cross-resistance between CCR5 inhibitors is likely
Higher risk of resistance using lopinavir/r monotherapy
Macaque study shows similar protection from rectal exposure using 2-hour pre- and 24-hour post exposure prophylaxis with tenofovir plus FTC compared to daily regimen
Thirteen NNRTI mutations linked to resistance to etravirine (TMC-125)
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
Protease inhibitors in pregnancy
Low rates of HCV treatment among eligible injection drug users
Effect of HCV and HIV on mortality among injecting drug users
HCV/HIV-co-infected IDUs are at increased risk of death from hepatitis-related death in the HAART era, compared with HCV-mono-IDUs
Long-term effectiveness of isoniazid prophylaxis on TB incidence in a cohort of IDUs
The dynamics of HCV transmission among injection drug users in St. Petersburg
Founder effect among HIV-positive IDU in Karachi, Pakistan
8th International Workshop on Clinical Pharmacology of HIV Therapy, April 2007, Budapest, Hungary
Drug-drug interactions
Pharmacokinetic data with existing antiretrovirals
Antiretroviral pharmacokinetics in special patient populations
Pharmacology of investigational drugs
Treatment access
G8 pledges to Africa are insufficient
Abbott sues ACT-UP Paris
UKs DFID support of Thailand
Roche patent for hepatitis C drug challenged in India
Pregnancy
Antiretroviral therapy and premature delivery in the United Kingdom and Ireland
Early response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
Mother to child transmission during exclusive breastfeeding
Surveillance of mother-to-child-transmission programmes: the case for universal screening
Rapid progression in infants infected with HIV despite single dose nevirapine prophylaxis
Side effects
30 cases of atazanavir-related kidney stones reported
Tenofovir and indinavir associated with increased risk of chronic renal failure in EuroSIDA study
Hepatitis coinfection
Scherings pegylated interferon approved for treating hepatitis C in HIV coinfected patients
Other news
Campaign launched for HIV-positive people denied access to stay in the UK
On the web
Meeting abstracts and reports
Journal articles and online resources
PDFs
Volume 8 Number 6/7 June/July 2007 PDF
HTB RSS
Early access
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
Mpox vaccine efficacy dramatically lower in people living with HIV
26 March 2025
All early access reports
Current issues
April 2025
March 2025
February 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate